文献速递主动脉疾病

单开窗医师改良腔内移植物修复2区主动脉弓病变至少3年随访

Zone 2 Aortic Arch Repair With Single-Fenestrated Physician-Modified Endografts, at Least 3 Years of Follow-up.
PubMed 文献 · J Endovasc Ther · 2023-12-04

该研究回顾了2015至2020年连续接受单开窗医师改良腔内移植物(PMEG)修复2区主动脉弓病变的患者,排除目标血管非左锁骨下动脉(LSA)者,共63例。结果显示早期及中期主要并发症与死亡率可接受,适用于急诊情况。

要点

  • 单开窗PMEG修复2区主动脉弓病变的早期及中期主要并发症与死亡率可接受。
  • 急诊组30天随访死亡率高于择期组,但长期随访无主动脉原因死亡。
  • 该技术适用于急诊情况,可单步完成主动脉修复与锁骨下动脉血运重建。

核心结论

  • 单开窗PMEG修复2区主动脉弓病变的早期及中期主要并发症与死亡率可接受,适用于急诊情况。

研究设计与样本

  • 回顾性分析2015至2020年连续接受单开窗PMEG修复2区主动脉弓病变的患者,排除目标血管非左锁骨下动脉者,共63例。

主要发现

  • 73%为男性,平均年龄65岁;25%为退行性动脉瘤,19%为夹层后动脉瘤,24%为急性B型夹层。
  • 52%为急诊手术,其中半数因主动脉破裂;70%的LSA开窗置入支架。
  • 30天随访中,卒中2例(3%),死亡6例(10%),其中4例因主动脉破裂治疗,1例发生逆行性主动脉夹层。
  • 至少3年随访(中位49个月)期间,无因内漏再干预,无支架断裂或移位,无主动脉原因死亡。
  • 亚组分析比较不同主动脉病变的腔内治疗,死亡率或包括卒中的合并症无显著差异;急诊与择期手术比较,手术时间相似(64 vs 65分钟),急诊组LSA开窗置入支架比例较低(52%),卒中频率无差异,急诊组30天随访死亡率较高,但长期随访无主动脉原因死亡。

关键数值与推荐

  • 单开窗PMEG治疗LSA在短期和中期是安全有效的选择,技术成功率为98%。
  • 该技术适用于多种主要病变,包括退行性、夹层相关、峡部破裂和栓塞性病变。
  • 该技术在急诊病例中始终可用且易于使用。

临床怎么用

  • 单开窗PMEG可用于2区主动脉弓病变的修复,并单步完成锁骨下动脉血运重建。
  • 该技术适用于包括退行性、夹层相关、峡部破裂和栓塞性病变在内的多种主要病变。
  • 该技术在急诊病例中始终可用且易于使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study is to report the efficiency and safety of single-fenestrated physician-modified endografts (PMEGs) in zone 2 aortic arch pathologies with at least 3 years of follow-up. METHODS: All consecutive patients with a pathological aortic arch who underwent aortic repair combined with homemade single-fenestrated stent-graft from 2015 to 2020 were reviewed. The patients with a target vessel different from the left subclavian artery (LSA) were excluded. RESULTS: A total of 63 patients were treated for a pathological arch in zone 2 with a single-fenestrated PMEG. 73% were male, and the mean age was 65 years old. 25% were treated for a degenerative aneurysm, 19% for a post dissection aneurysm and 24% for an acute type B dissection. 52% of the patients were treated as an emergency and half of those for an aortic rupture. The LSA fenestration was stented in 70%. During 30 days of follow-up, 2 strokes (3%) were reported, 6 patients (10%) died with 4 of those treated for aortic rupture and 1 had a retrograde aortic dissection. During at least 3 years of follow-up (median 49 months), no reintervention was needed for endoleaks, there was no stent fracture or stent migration. No patient died from an aortic cause. Subgroup analysis comparing the endovascular treatment for various aortic pathologies did not find significant differences in death rate or comorbidity including stroke. When comparing emergent and elective aortic repair, operating time was similar (64 vs 65 minutes), and the LSA fenestration was less frequently stented (52%) in the emergency group. There was no difference in stroke frequency. There was a higher rate of death in the emergency group at 30 days of follow-up, but no patient died from aortic cause in the long-term follow-up. CONCLUSIONS: Aortic arch repair with single-fenestrated PMEGs for zone 2 pathological arch disease is associated with acceptable early and midterm major morbidity and mortality. It is suitable for emergency situations.Clinical ImpactSingle-fenestrated PMEG for the left subclavian artery is a safe and efficient option in the short and medium term for the treatment of the aortic arch in zone 2 with 98% technical success. It allows for aortic repair and subclavian artery revascularization in a single step for all patients. It is suitable for a range of main pathologies, including degenerative, dissection-related, isthmus rupture, and embolic pathologies. Additionally, it is always available and easily utilized in emergency cases.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Bacri C, Ata Ozdemir B, Hireche K, et al. Zone 2 Aortic Arch Repair With Single-Fenestrated Physician-Modified Endografts, at Least 3 Years of Follow-up. J Endovasc Ther. 2023. PMID: 38049943. doi:10.1177/15266028231215779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。